This basic science study demonstrates that Ca2+ sensitivity in myofibrils is directly due to Ca2+ binding to troponin C.
Answers are grounded in this paper and cite their sources.
Does not inform clinical management; leaves open therapeutic targeting of troponin C in human heart failure models.
It was previously shown that when rabbit skeletal myofibrils are titrated with Mg2+ AMPPNP under conditions that result in the dissociation of cross-bridges from the thin filaments (i.e. 50% ethylene glycol, 0 degrees C), Ca2+-sensitive, biphasic binding is observed. These titrations have been repeated using myofibrils from which the troponin C has been selectively removed. The disappearance of both Ca2+ sensitivity and biphasic binding is taken as evidence that the Ca2+ sensitivity is due to Ca2+ binding to troponin C and the biphasic binding of Mg2+ AMPPNP observed in intact myofibrils is not due to packing constraints or steric hindrance.
No takes yet. Share an insight, caveat, or question.
Robert E. Johnson (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: